Timothy Feger, MD
Allergy & Immunology · Louisville, KYNPI 1215937693
Payments from drug & device makers
Across 520 payments — averaging $19.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- CSL Behring$2K
- Regeneron Healthcare Solutions, Inc.$1K
- GSK$1K
- Sanofi$698
- Kaleo, Inc.$530
- plus $3K from 24 others
What the payments were for
- Consulting fees$280%
- Food & beverage$9,921100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 73 | $1,737 |
| CSL Behring | 82 | $1,561 |
| Regeneron Healthcare Solutions, Inc. | 54 | $1,259 |
| GSK | 79 | $1,226 |
| Sanofi | 40 | $698 |
| Kaleo, Inc. | 37 | $530 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $443 |
| Teva Pharmaceuticals USA, Inc. | 28 | $374 |
| Pfizer | 12 | $248 |
| Genentech USA, Inc. | 12 | $239 |
| Novartis | 11 | $217 |
| Amgen | 12 | $187 |
| Boehringer Ingelheim | 11 | $151 |
| Pulmonx Corporation | 1 | $149 |
| Pharming Healthcare, Inc. | 6 | $122 |
| Grifols USA, LLC | 7 | $115 |
| Alk-abello, Inc | 5 | $113 |
| Blueprint Medicines Corporation | 3 | $113 |
| Biocryst US Sales Co., LLC | 4 | $95 |
| Optinose US, Inc. | 6 | $76 |
| Octapharma USA, Inc. | 3 | $60 |
| LEO Pharma Inc. | 2 | $41 |
| Sanofi-aventis U.S. LLC | 2 | $40 |
| Mylan Specialty L.p. | 2 | $36 |
| ADMA Biomanufacturing LLC | 1 | $28 |
| Shire North American Group Inc | 1 | $22 |
| Hikma Pharmaceuticals USA | 1 | $21 |
| Bio Products Laboratory USA, Inc. | 1 | $20 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $16 |
| Incyte Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEZSPIRE$423
- FASENRA$423
- DUPIXENT$347
- AIRSUPRA$278
- NUCALA$221
- BREZTRI$171
- CHARTIS CATHETER$149
- ZEPHYR DELIVERY CATHETER$149
- ZEPHYR ENDOBRONCHIAL VALVE$149
- PULMONX CHARTIS TABLET CONSOLE$149
- Hizentra$116
How this compares
$9,949 in reported general payments places this provider in the 60th percentile of 66 allergy & immunology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breo ElliptaFluticasone/Vilanterol | 47 | $25,716 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $25,172 |
| Epinephrine | 98 | $23,383 |
| Advair HfaFluticasone Propion/Salmeterol | 26 | $16,523 |
| SymbicortBudesonide/Formoterol Fumarate | 48 | $15,202 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $11,537 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 77 | $8,845 |
| DuleraMometasone/Formoterol | 19 | $7,436 |
| BreynaBudesonide/Formoterol Fumarate | 19 | $4,546 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 122 | $3,547 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 23 | $2,912 |
| Azelastine Hcl | 125 | $2,836 |
| Ipratropium Bromide | 96 | $2,488 |
| Mometasone Furoate | 26 | $1,902 |
| Montelukast Sodium | 192 | $1,601 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta, Trelegy Ellipta | $1,226 | $50,88874 claims |
| AstraZenecaSymbicort, Breztri Aerosphere | $1,737 | $26,73966 claims |
| Hikma Pharmaceuticals USAEpinephrine | $21 | $23,38398 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 66 allergy & immunology providers in Kentucky.
Other allergy & immunology in Louisville
- James SublettLouisville$1.7M
- James SublettLouisville$481K
- Stephen PollardLouisville$463K
- Douglas LotzLouisville$199K
- Timothy FranxmanLouisville$162K
- Jeremy JonesLouisville$149K
- Mark CorbettLouisville$138K
- Kali GeraceLouisville$30K
- David PallaresLouisville$22K
- Joseph TurbyvilleLouisville$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.